The U.S. faces a tight timeline to accumulate enough data on a Covid-19 vaccine reworked to address new variants, with late spring emerging as the deadline for a fall vaccination campaign, federal officials said Wednesday.
The Food and Drug Administration’s independent vaccine advisory panel met to begin outlining the broader U.S. Covid booster strategy — namely, who should receive additional doses and when, and whether and how the vaccines should be reformulated
→ Continue reading at Politico
